PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30539634-5	2019	We loaded doxorubicin (DOX) as anticancer biomolecule into the pores of MSN and capped with COP.	Doxorubicin	10-21	caspase recruitment domain family member 16	Homo sapiens	92-95	
94197-14	1979	Here particularly the COP-scheme proved to be favourable, if necessary in connection with bleomycin, adriamycin or methotrexat; also BCNU or dakarbacin are possible.	Doxorubicin	101-111	caspase recruitment domain family member 16	Homo sapiens	22-25	
364284-1	1978	The results of a chemotherapy regimen utilizing adriamycin in combination with vincristine, prednisone plus or minus cyclophosphamide (CHOP-HOP) for the treatment of non-Hodgkin lymphoma are compared to those of a non-adriamycin containing combination (COP).	Doxorubicin	48-58	caspase recruitment domain family member 16	Homo sapiens	253-256	
30539634-9	2019	The combination of DOX with COP (COP@DOX-MSN) showed even higher ROS level, demonstrating a cytotoxic synergism of drug and nanoparticle in terms of ROS generation.	Doxorubicin	19-22	caspase recruitment domain family member 16	Homo sapiens	33-44	
30539634-5	2019	We loaded doxorubicin (DOX) as anticancer biomolecule into the pores of MSN and capped with COP.	Doxorubicin	23-26	caspase recruitment domain family member 16	Homo sapiens	92-95	
23169503-2	2013	We studied standard agents with rituximab plus pegylated liposomal doxorubicin (DR-COP) in an attempt to provide a more practical approach to therapy while ascertaining rates of response, potential infectious complications, and prognostic role of biologic markers.	Doxorubicin	67-78	caspase recruitment domain family member 16	Homo sapiens	83-86	
14719457-7	2003	COP (CHOP minus adriamycin) therapy has been given every four months on an out-patient basis.	Doxorubicin	16-26	caspase recruitment domain family member 16	Homo sapiens	0-3	
14653077-5	2003	The CR rate and 5-year survival rate of patients who were treated by the scheme of doxorubicin, cyclophosphamide, vincristine and prednisone (CHOP) were higher than those treated by the scheme of cyclophosphamide, vincristine, prednisone and etoposide (COP + VP16) (P < 0.05).	Doxorubicin	83-94	caspase recruitment domain family member 16	Homo sapiens	253-256	
11699226-16	2001	We conclude that the substitution of DaunoXome for doxorubicin in the CHOP regimen to form COP-X provides excellent efficacy against non-Hodgkin"s lymphoma.	Doxorubicin	51-62	caspase recruitment domain family member 16	Homo sapiens	91-94